血红蛋白变体作为稳定药物的目标
Miroslava Žoldáková1, Michal Novotný2, Krishna P Khakurel3
1Faculty of Science, Pavol Jozef Šafárik University in Košice, Park Angelinum 19, 040 01 Košice, Slovakia.
Molecules (Basel, Switzerland)
|January 25, 2025
概括
研究审查新的治疗方法,以稳定血红蛋白,一种运输氧气的蛋白质. 这些策略,包括小分子和基于蛋白质的疗法,旨在改善血红蛋白功能和治疗遗传血红蛋白疾病.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 血红蛋白 (Hb) 对于红细胞中的氧气运输至关重要,与各种连接体相互作用.
- 在Hb链中的遗传变异会导致诸如状细胞病和血病等疾病,这带来了重大的临床挑战.
- 存在许多Hb变异,其中大量被归类为不稳定,需要针对性的治疗干预.
研究的目的:
- 审查目前稳定血红蛋白变异的研究进展.
- 探索遗传性血红蛋白病变的新型治疗策略.
- 突出基因型驱动方法对个性化治疗的潜力.
主要方法:
- 审查关于血红蛋白研究的现有文献.
- 对治疗策略的分析,包括全调节剂,药理伴侣和抗氧化剂治疗.
- 检查基于蛋白质的新策略,如工程化血红蛋白结合蛋白.
主要成果:
- 通过各种治疗方法,研究已经在改善血红蛋白稳定性和氧 afinity方面取得了进展.
- 有超过1500个Hb变体被记录在案,其中超过116个被确定为不稳定,这强调了需要稳定性的需要.
- 人工合成的血红蛋白结合蛋白显示出有前途的新疗法.
结论:
- 迫切需要为血红蛋白开发变体特定的稳定选择.
- 新型基于蛋白质的策略为小分子药物提供了有希望的替代品.
- 对Hb稳定和带结合修饰的持续研究可以导致更有效的血红蛋白病变治疗方法.
关键词:
2,3-二二糖酸盐 (2,3-BPG) 是一种波尔效应是一种波尔效应.全osteric调节的调节.遗传变异是一种遗传变异.血红蛋白 (Hb) 在血红蛋白 (Hb) 中.氧的亲和力 氧的亲和力具有氧结合特性.蛋白质工程工程 蛋白质工程状细胞病 (SCD) 是一种状细胞疾病.泰拉塞米亚症是一种疾病.更多相关视频
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.7K
09:35Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
14.0K
相关概念视频
Gene Families
8.7K
Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
8.7K
Hemoglobin
3.2K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
3.2K
Oxygen Transport in the Blood
2.4K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
2.4K
Multiple Allele Traits
34.0K
The Concept of Multiple Allelism
34.0K
Cooperative Allosteric Transitions
7.8K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.8K
Drug Binding to Blood Components
106
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
106
